![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 38/50 | (2006.01) |
A61K 39/00 | (2006.01) | ||
C07K 16/28 | (2006.01) | ||
C12N 9/78 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 3496743 |
(13) | Kind of document | T |
(96) | European patent application number | 17840420.8 |
Date of filing the European patent application | 2017-09-08 | |
(97) | Date of publication of the European application | 2019-06-19 |
(45) | Date of publication and mention of the grant of the patent | 2022-02-09 |
(46) | Date of publication of the claims translation | 2022-04-11 |
(86) | Number | PCT/US2017/050816 |
Date | 2017-09-08 |
(87) | Number | WO 2018/032020 |
Date | 2018-02-15 |
(30) | Number | Date | Country code |
201662372092 P | 2016-08-08 | US | |
201762524286 P | 2017-06-23 | US |
(72) |
LOWE, David , US
ROWLINSON, Scott, W. , US
ALTERS, Susan , US
AGNELLO, Giulia , US
|
(73) |
Immedica Pharma AB ,
Solnavägen 3H, 113 63 Stockholm,
SE
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Kompozicijos ir metodai, skirti vėžio gydymui arginino deplecija ir imunoonkologiniais preparatais |
COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ARGININE DEPLETION AND IMMUNO ONCOLOGY AGENTS |
Payment date | Validity (years) | Amount | |
2025-07-10 | 9 | 208.00 EUR |
2026-09-08 |